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Abstract Mitochondrial DNA depletion syndromes are a 
group of autosomal recessive hereditary disorders charac-
terized by reduction of the amount of mitochondrial DNA 
in the affected tissue (muscle, liver, brain, or kidneys). We 
report a case of an infant with myopathy, deafness, periph-
eral neuropathy, nephrocalcinosis, proximal renal tubulop-
athy, moderate lactic acidosis, and a novel mutation of the 
RRM2B gene.
Mitochondrial DNA depletion syndromes are a group of 
autosomal recessive hereditary disorders characterized by 
reduction of the mitochondrial DNA amount in the affect-
ed tissue (1). Depletion of mitochondrial DNA can affect 
specific tissues or combination of organs and tissues in-
cluding muscles, liver, brain, or kidneys (2,3).
Different defects of nuclear genes may lead to different 
clinical manifestations, such as hepatocerebral syndrome, 
encephalopathy, or myopathy. One of the recently iden-
tified genes for mitochondrial DNA depletion syndromes 
is RRM2B, which encodes an isoform of a small subunit of 
ribonucleotide reductase. This enzyme plays an essential 
role in nucleotide synthesis, converting ribonucleotides to 
deoxyribonucleotides. Since 2008, 14 mutations of RRM2B 
gene have been reported (3,4). All the reported mutations 
are unique and there is no mutation that appears in more 
than one family (1-4).
All reported patients had myopathy and primary lactic 
acidosis. More than a half of them died before the fourth 
month of age. The oldest patient with RRM2B mutation 
was a 42 years old woman with clinical findings suggestive 
of neurogastrointestinal encephalopathy (5). In this report, 
we review a case of an infant with muscular hypotonia, my-
opathy, peripheral neuropathy, deafness, nephrocalcinosis, 
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proximal renal tubulopathy, moderate lactic acidosis, and a 
novel mutation of the RRM2B gene.
CASe report
The patients was a male Caucasian baby, born by spon-
taneous vaginal delivery at 38 weeks of gestation, (birth 
weight 2950 g, birth length 50 cm, Apgar scores 10/10). He 
was the second child of non-consanguineous parents. The 
elder child was healthy. The mother had well-controlled 
hypothyreosis due to thyroidectomy performed 12 years 
earlier and since then she had been using hormone re-
placement therapy (levothyroxine sodium). Family history 
was negative for genetic and hereditary diseases. During 
the first two months of life while he was at home, the baby 
had poor appetite and failed to thrive.
On admission, at the age of 3 months, he had growth de-
lay: body weight 3800 g (3rd percentile), body length 58 
cm (25th percentile), and head circumference 38 cm (3rd 
percentile). Except for the generalized hypotonia (“floppy 
infant”) and inability to completely close the left eyelid, all 
other physical findings were normal.
Complete blood count and other biochemical findings 
(routine kidney and liver function tests), including creatine 
phosphokinase, were within the reference range. Plasma 
lactate levels were slightly elevated and ranged from 2.0 
mmol/L to 8.0 mmol/L (reference range 0.1-2.2 mmol/L). 
Urinary calcium/creatinine ratio ranged from 2.9 mmol/L 
to 8.1 mmol/mmol (upper reference value 2.2 mmol/
mmol). Parathyroid hormone was 13.2 pg/mL (15-65 pg/
mL) and vitamin D 142 mmol/L (30-100 mmol/L). Tubular 
reabsorption of renal phosphate per deciliter glomerular 
filtrate (TP/GFR) was 0.41. Plasma levels of amino acids – 
threonine, valine, cystine, beta alanine, histidine, argin-
ine, and praline were significantly reduced. The results of 
urine analysis showed: pH 7.0, specific gravity 1000, pro-
teins 3+, glycosuria 55.5 mmol/L, microalbuminuria 26.3 
FiGure 1. Computed tomography scan of the brain showing 
microlacunar hypodense zones in periventricular white matter 
of the frontal lobes.
FiGure 2. Sequence analysis revealed a mutation c.707G>A,p.Cys236tyr in rrM2B affecting a phylogentically highly conserved 
amino acid.
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to 300 mg/L (upper reference value 16 mg/L), albumin/
creatinine ratio >20.3 mg/mmol (upper reference value 1.4 
mg/mmol). Concentrations of alanine, isoleucine, leucine, 
ornithine, and lysine in urine were significantly elevated. 
Electrocardiography and echocardiography findings were 
normal. Ultrasonography of the urinary tract showed that 
both kidneys were of normal shape and size, with hyper-
echogenic renal pyramids. Computed tomography of the 
abdomen showed calcium deposits in the renal pyramids 
of both kidneys. Brain ultrasound was normal. Computed 
tABle 1. Clinical and genetic features of reported cases with rrM2M mutations
No
reference 







1 1 Family 1 Total of 3 subjects; a brother 
and two sisters, all with 
same clinical features: 
trunk hypotonia, proximal 
tubulopathy
NA NA ++ NA Severely decreased 






4 Family 2 Subject 1: trunk hypotonia, 
proximal tubulopathy, 
seizures
NA NA ++ NA Combined complex I, 
III, and IV deficiency
Compound heterozy-
gote for a splice-site 
mutation (IVS3-2 A>G) 
and missense mutation 
(nt 580 G>A)
5 Subject 2: trunk hypotonia, 
proximal tubulopathy
6 Family 3 Subject 1: respiratory dis-
tress, hypotonia
NA NA ++ NA Few RRFs and lack 
of histochemical 
cytochrome c oxidase 
reaction in all fibers
Compound heterozy-
gote for two missense 
mutations (nt 190 
t > C, W64R, and nt 581 
A>G,E194G)
7 Subject 2: Trunk hypotonia, 
vomiting, diarrhea
NA NA ++ NA RRFs, COX deficiency 3-bp inframe deletion 
(nt 253-255ΔGAG, 
ΔGlu85) and a missense 
mutation (nt 707 G>T, 
C236F)
8 2 Deafness, progressive weak-




showed the presence 




++ NA RRFs with modified 
Gomori trichrome 
stain and ragged-blue 
fibers with the SDH 
stain. Lipid accumula-
tion
Homozigous for a c.671 
t > G mutation in exon 6
9 Failure to thrive, failure 
to gain developmental 
milestones, hypotonia, 
microcephaly, respiratory 
failure, urinary infections, 
intolerance to oral feeds, 
peripheral pigmentary 
retinopathy
Bilateral and nearly 
symmetrical non-
enhancing areas 
of abnormal signal 
reduced diffusion 
in the white mat-
ter. Spectroscopy 
showed lactate peak 




+ NA Scattered fibers with 
increased staining for 
SDH
Compound heterozy-
gous for a missense 
mutation in exon 8 
(c.846 G>C) and 1-bp 
deletion in exon 9 
(c.920 delA)
10 Progressive hypotonia, 
failure to thrive and micro-
cephaly, multiple respiratory 
infections
NA + + NA Scattered RRFs COX 
negative or COX 
deficient
Compound heterozy-
gous for a missense 
mutation in exon 9 
(c.949 t > G) and 1-bp 
deletion in exon 6 
(c.584 delG)
11 3 Floppiness, congenital deaf-
ness, glycosuria









12 Floppiness, tubulopathy NA NA ++ NA NA IVS3-2A>C / c.C328T
p.R110C
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tomography of the brain (Figure 1) revealed microlacunar 
hypodense zones in periventricular white matter of the 
frontal lobes that corresponded to ischemic lesions. Both 
lateral ventricles, as well as the third ventricle, were slightly 
dilated. Subarrachnoid spaces in the Sylvian fissures were 
moderately expanded on both sides (Figure 1).
Electroencephalography showed non-specific electrocor-
tical dysrhythmia. Electromyography and nerve conduc-
tion velocity tests revealed neurogenic lesion of mild to 
moderate degree on all tested muscles of upper and lower 
extremities, more expressed distally. Denervation activity 
was observed in all tested muscles. Neurographic parame-
ters pointed to a deceleration of transmission for all tested 
motor nerves and lowered amplitudes for axillar and me-
dian nerves on the left.
Ophthalmologic investigations revealed a megacornea 
(right eye 12.5 mm, left eye 12 mm) on both sides. Anterior 
eye segment and fundus were normal. Transient-evoked 
otoacoustic emission did not register any response. There 
was a doubt that it could be the case of sensorineural deaf-
ness with a hearing limit lower than 35 dB Hearing Level.
Muscle biopsy (musculus vastus lateralis) revealed no 
signs of atrophy, inflammation, and fibrosis. Vacuolar 
myopathy was seen on all intersections. The speci-
mens were dyed using periodic acid-Schiff staining meth-
od and the findings were negative. Aggregation of mi-
tochondria was seen only in some fibers. Pathognomic 
“ragged red” fibers were not seen. Neural cell adhesion 
molecule was expressed on sarcolemma and in cytoplasm, 
but only a few fibers indicated expression on the neuro-
muscular connection.
Soon after admission to the intensive care unit, pneumonia 
with complete atelectasis of the left lung was diagnosed. 
Mechanical ventilation was initiated due to respiratory fail-
ure, along with appropriate antibiotic therapy. Further clini-
cal course was progressive and complicated with recurrent 
lung infections and sepsis. Despite of the hypercaloric en-
teral intake, he progressively lost body weight. His psycho-
motor skills continuously deteriorated and he developed 
progressive external ophthalmoplegia. The patient died at 
the age of 8 months.
The mother and the patient had normal karyotypes – 46, 
XX and 46, XY, respectively; both with pericentric inver-
sion of the chromosome 9 (p11q13). The father had male 
karyotype (46, XY) with deletion of one copy of exon 7 
SMN1 gene. Investigation of the RRM2B gene from ge-
nomic DNA isolated from blood of the patient revealed 
a missense mutation c.707G>A, p.Cys236Tyr, which af-
fected a highly conserved amino acid. The mutation al-
13 4 brothersFeeding difficulties, failure 





++ NA COX deficiency and 
accumulation of fat in 
muscle fibers
Missense mutation in 
exon 7 (c.686 G>T)
14 Feeding difficulties, failure 
to thrive, severe muscular 
hypotonia, seizures
Generalized atrophy‡ ++ ++ NA COX deficiency and 
accumulation of fat in 
muscle fibers
Missense mutation in 








hypodense zones in 
periventricular white 
matter of the frontal 
lobes, slightly dilated 
lateral ventricles and 
third ventricle, 
subarachnoid spaces 

















thy, aggregation of 




*Abbreviations: CK – creatine phosphokinase; eMG – electromyography; rrF – ragged red fibers; CoX – cyclooxygenase, SDH – succinate dehydro-
genase; + – moderately elevated levels, ++ – significantly elevated levels, NA – data not reported.
†Computed tomography (Ct) of the brain.
‡Magnetic resonance imaging (Mri) of the brain.
tABle 1. Continued. Clinical and genetic features of reported cases with rrM2M mutations
No
reference 
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lele was the only detectable, making a homozygous mu-
tation likely (Figure 2).
DiSCuSSioN
There are three forms of mitochondrial DNA depletion 
syndromes – myopathic, encephalomyopatic, and hepa-
tocerebral (3). The incidence of mitochondrial encephal-
opathy in children is about 1 per 5000-11 000 newborns. 
Mitochondrial disease is caused by genetic defects of mi-
tochondrial DNA or nuclear genes encoding proteins of 
the respiratory chain enzyme complexes. Replication of 
mitochondrial DNA is regulated by nuclear genes, encod-
ing nucleotide supply, as well as mitochondrial DNA repli-
cation process. The lactate level in plasma is moving from 
normal to significant lactic acidosis (6).
Depletion of mitochondrial DNA is associated with muta-
tions in the nuclear genes that affect metabolism of mi-
tochondrial nucleotides and replication of mitochondrial 
DNA. These genes exert their action by either directly affect-
ing the mitochondrial DNA replication fork (POLG, POLG2, 
PEO1) or regulating the mitochondrial deoxynucleotide 
triphosphate pool (TYMP, TK2, DGUOK, SUCLA2, SUCLG1, 
ANT1). In patients with mitochondrial depletion syndrome, 
a novel mutation of RRM2B was diagnosed, which presents 
with early muscular hypotonia, renal tubulopathy, diarrhea, 
lactic acidosis, and rapid progressive lethal course (3).
All the patients with autosomal recessive RRM2B muta-
tions described until now have had myopathy and most 
of them have had renal involvement. The disease usually 
begins during infancy with myopathy and lactic acidosis 
(3,4). In our patient, plasma lactate levels shifted from ini-
tially normal values up to 8 mmol/L.
So far, congenital deafness has been described only in 3 pa-
tients with RRM2B gene mutation (3,6). In our patient, tran-
sient-evoked otoacoustic emission showed no response. 
Brain imaging findings have been reported in only 2 pa-
tients. One had bilateral diffused reduction of white mat-
ter and the other generalized atrophy of the brain (6,7). Our 
patient also had mild abnormalities of the brain (ventriculo-
megalia). Electromyography and nerve conduction velocity 
tests revealed neurogenic lesions on tested muscles on all 
extremities. Denervation activity was registered in all tested 
muscles. Motor nerve conduction study showed decelera-
tion of transmission velocity for all tested nerves. This is an 
important finding because until now peripheral neuropa-
thy has not been described in patients with RRM2B mu-
tation, but only in patients with POLG mutation (7). Mito-
chondrial encephalomyopathy is important in differential 
diagnosis of neonatal muscular hypotonia (Table 1).
It is still unknown why mutations are manifested only on 
specific organs when they are expressed ubiquitously. The 
reason for this could be the short lifetime of these patients, 
which prevents us from detecting changes in other or-
gans. So far, mutation has been manifested in all patients 
as an early developed myopathy and in most of them as 
renal involvement. Our patient had myopathy, congeni-
tal deafness, nephrocalcinosis, proximal tubulopathy, and 
lactic acidosis. Peripheral neuropathy has still not been 
described in any of the other patients with RRM2B muta-
tion. In our patient, the disease had a progressive course 
with fast psychomotor delay, progressive external ophthal-
moplegia, failure to thrive, and respiratory insufficiency.
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